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A B S T R A C T
Vulvar Morbus Paget (MP) represents a rare intraepithelial adenocarcinoma. It accounts for less than 1% of all vul-
var neoplasia and usually appears in postmenopausal women. Histologically it is analogous to Paget’s disease of the
breast. The most common clinical symptom is pruritus. The lesion appears as an erythematous or as an eczematous le-
sion with islands of hyperkeratosis. Occasionally, single anaplastic Paget’s cells can be found on the vulvar smears
which make cytological diagnosis of the disease possible. However, the disease can be diagnosed only by biopsy. We pres-
ent a case of 49-year old woman with vulvar symptoms of pruritus, who had liver and kidney transplantation two years
ago. During the standard gynecological examination the vulvar smear was taken for cytological evaluation. The smear
was scanty, with inflammatory background, overloaded with squamae. There were two types of cells: dysplastic squa-
mous cells from lower layer of the epithelium and the single, anaplastic cells with a high nuclear:cytoplasmic ratio who
possessed eccentric, large nucleus. Nucleoli were rare. Cytoplasm varied from pale and delicate to densely basophilic. Ac-
cordingly, cytological diagnosis vulvar intraepithelial neoplasia (VIN III) with differential diagnosis of vulvar Paget’s
disease was made. The pathological verification supported the diagnosis of MP and an immunohistochemistry panel
confirmed type III of Paget’s disease and an evaluation of bladder was suggested.
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Introduction
The most common neoplasia of the vulvar skin is
squamous vulvar intraepithelial neoplasia (VIN) and in
the most cases it is associated with atypical keratinocytes
of human papillomavirus (HPV) positive cells. It is con-
sidered as a precursor of vulvar squamous cell carci-
noma. Vulvar Morbus Paget (MP) represents a rare ade-
nocarcinoma1, first described in 1901 by Dubreuilh and it
is accounts for less than 1% of all vulvar neoplasia2.
Histologically it is similar to Paget’s disease of the breast
and vulva is the most common extramammarial loca-
lization3. The histogenesis is not completely understood
but it is known that MP occurs most frequently in areas
rich with apocrine glands and it seems that the disease is
not connected with human papillomavirus (HPV) in-
fection4,5. A high incidence of other malignancies (breast,
colon, cervix, ovary and bladder) warrants careful exami-
nation of these patients6. In cases of Paget’s disease of
the vulva, primary cytological diagnosis is possible7. The
cytologic differential diagnosis must include squamous
intraepithelial lesion, nonkeratinizing squamous cell
carcinoma, adenocarcinoma of other sources8, lichen
sclerosis and malignant melanoma9. But definitive diag-
nosis can be made only by histology.
Case Report
We present a case of 49-year old woman, menopausal
for six years with history of the vulvar skin irritation,
itching and diffuse painfull erythematous lesions of the
labia major and the perineum. The main symptoms ap-
peared two years after kidney and liver transplantation.
During the standard gynecological examination, cervical
and vulvar smears were taken. Low-grade squamous
intraepithelial lesion was found on routinely taken cervi-
cal smear. The vulvar smear was very scanty. On the in-
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flammatory background, in the clusters of squamae the
small dyskaryotic cells were found, predominantly single
with nuclear hyperchromasia, irregular nuclear mem-
brane and distinctly reduced cytoplasm with abnormal
keratinization (Figure 1, 2) along with the large, tumor
single cells. Tumor cells (Figure 3, 4) were large, with a
high nuclear:cytoplasmic ratio and possessed a central or
eccentric, large nucleus. Nucleoli were rare. Cytoplasm
varied from small densely basophilic to pale and abound.
Cytological diagnosis of vulvar intraepithelial neoplasia
III (VIN III) was established and further procedure was
recommended. After the positive Collins’ test the biopsy
was done. Histologically, surface was covered by squa-
mae, the epithelium and basal layer was full of large,
anaplastic – Paget’s cells, single or in small clusters (Fig-
ure 5). Immunohistochemically the tumor cells were CK
7 and EMA strongly positive (Figure 6) and CEA and
GCDFP-15 scanty positive. CK 20, Estrogen, Ca-125,
PAS and alcian-blue were negative. Histopathological
evaluation with immunohistochemical features and clini-
cal data gave us the definitive diagnosis of the Paget dis-
ease type III and an evaluation of bladder was suggested.
Discussion
Vulvar Morbus Paget appears as either an erythema-
tous or an eczematous lesion like red to pink area with
S. Kataleni} Simon et al.: Vulvar Paget Disease, Coll. Antropol. 34 (2010) 2: 649–652
650
Fig. 1. Squamae, dyskaryotic squamous cells from inner layer
of epithelium and anaplastic cell (Papanicolaou x400).
Fig. 2. Inflammatory background with squamae and
dyskaryotic cells (Papanicolaou x400).
Fig. 3 and 4. Paget’s cell (Papanicolaou x1000).
Fig. 5. Paget’s cells extending into the upper epithelium
(HE – hemalaun eosin x400).
Fig. 6. Cytokeratin 7 positive Paget’s cells (x100).
white islands of hyperkeratosis, most often in postmeno-
pausal women around 65 years of age10, predominantly
on the labia major, the labia minor and in the areas of the
perineum. The most common clinical symptom is pruri-
tus. Because of its clinical resemblance to dermatosis,
these patients may be treated with various topical medi-
cations for some time before the diagnosis is made by
biopsy11. Based upon the origin of the neoplastic cells the
disease has been recently subclassified into three distinct
types: type I is primary vulvar cutaneous Paget’s disease;
type II is Paget’s disease as a manifestation of an associ-
ated adjacent primary anal, rectal or other-non-cutane-
ous adenocarcinoma and type III is pagetoid urothelial
intraepithelial neoplasia (PUIN), as a manifestation of
bladder neoplasia. Type I can be further subclassified as
type 1a, 1b and 1c. Type 1a is primary vulvar intra-
epithelial Paget’s disease – as adenocarcinoma in situ
where the Paget’s cells can be identified by scraping from
attached areas. Type 1b is MP as primary vulvar intra-
epithelial Paget’s disease with invasion. Type 1c is vulvar
Paget’s disease presenting as a manifestation of primary
underlying vulvar adenocarcinoma (adenocarcinoma of
the Bartholin’s gland, specialized anogenital glands, or
other vulvar glandular structures12). The distinction be-
tween these subtypes can be made by immunohisto-
chemistry panel of the antibodies. The Paget’s cells are
positive for low weight cytokeratins 7 (CK7), carcino-
embryonic antigen (CEA), antiepithelial membrane anti-
gen (EMA), grosses cystic disease fluid protein-15
(GCDFP-15) and show PAS positive material13. Primary
perianal Paget’s disease (type II) is usually immuno-
reactive for cytokeratin 20 and negative for GCDFP-1514.
Cervical adenocarcinoma manifesting as vulvar Paget’s
disease could be HPV positive especially for oncogenic
types 16 or 18. Typically Paget’s cells are HPV negative.
Paget’s disease – type III does not contain mucin, PAS-
-positive material, CEA, or GCDFP-15. The cells of PUIN
are immunoreactive for CK 7 and may be cytokeratin 20
positive and uroplakin III positive. Melanoma cells, in
contrast, are negative for these markers, but positive for
S-100 polyclonal antibody and antihuman melanoma
HMB-4515. The treatment and prognosis of vulvar Pa-
get’s disease depends on the type of disease and of the
underlying carcinoma. Because of the possible reappear-
ance of the disease close cytological follow-up for a longer
period of time is essential before excluding recurrence.
MP with its pathognomonic Paget’s cells is similar wher-
ever it occurs. The preliminary cytological diagnosis of
vulvar Paget’s disease is possible only if the cell sample is
representative.
Adequate sample for correct diagnosis of vulvar Pa-
get’s disease must include two different types of the cells:
squamous cells along with squamae with or without ab-
normality of nuclei and the Paget’s cells. Sometimes
these cells are scanty and mixed with squamous cells,
and are hard to be noticed, so that careful and skilled
analysis is required to avoid misdiagnosis. So knowledge
of the cytologic features of MP could provide a highly
probable cytologic diagnosis of the disease and should
alert the clinician to the need for immediate biopsy2. Of
course, clinical history and anamnestic data of patients
are crucial in helping make an accurate cytological diag-
nosis. However, the correct diagnosis can be made only
by biopsy with the use of the immunohistochemical panel
of the antibodies. Therapy for vulvar PUIN is directed to-
ward the bladder urothelial neoplasm while the vulvar
pagetoid intraepithelial neoplastic process is treated con-
servatively. Paget’s disease of the vulva is a rare neo-
plasm but it should be considered, especially in older
women, and vulvar smears should be taken whenever
symptoms are present.
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PAGETOVA BOLEST STIDNICE – PRIKAZ SLU^AJA
S A @ E T A K
Pagetova bolest (PB) vulve predstavlja rijedak oblik intraepitelnog adenokarcinoma. Obuhva}a manje od 1% svih
zlo}udnih neoplazma vulve. Javlja se ~e{}e u postmenopauzi a histolo{ki je istovjetan Pagetovoj bolesti dojke. Vulva je
naj~e{}a ekstramamarna lokalizacija. Klini~ki se vidi ograni~eno eritematozno uzdignu}e s otocima hiperkeratoze. Pri-
kazan je slu~aj 49-godi{nje transplantirane pacijentice (multiorganska transplantacija: bubrega i jetre) sa simptomima
svrbe`i i nelagodnog peckanja u podru~ju velikih usana i perineuma. Prilikom pregleda uzeo se i obrisak stidnice za
citolo{ku analizu. U oskudnom materijalu na upalno promijenjenoj pozadini preparata uz mno{tvo bakterija i skvama
na|ene su dvije vrste stanica: plo~aste diskarioti~ne stanice iz dubljeg sloja epitela te pojedina~ne anaplasti~ne stanice u
kojima dominira poreme}en odnos jezgre i citoplazme, s ekscentri~nom i hiperkromatskom jezgrom, ponegdje istak-
nutijim nukleolima te ne{to obilnijom bazofilnom citoplazmom. Citolo{ki nalaz je uputio na vulvarnu neoplaziju (VIN
III) uz diferencijalnu dijagnozu Pagetove bolesti. Nakon pozitivnog Collins-ovog testa u~inila se ekscizija lezije te je
patolo{ka verifikacija potvrdila Pagetovu bolest a imunohistokemijski panel uputio na tip III Pagetove bolesti.
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